Exforge and Novolog drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Exforge (amlodipine besylate; valsartan) and Novolog (insulin aspart recombinant). Common drug interactions include drug ineffective among females and chronic kidney disease among males.

The phase IV clinical study analyzes what interactions people have when they take Exforge and Novolog. It is created by eHealthMe based on reports of 77 people who take the same drugs from the FDA, and is updated regularly.

What is Exforge?

Exforge has active ingredients of amlodipine besylate; valsartan. It is often used in high blood pressure. eHealthMe is studying from 13,350 Exforge users. Check the latest studies of Exforge.

What is Novolog?

Novolog has active ingredients of insulin aspart recombinant. It is often used in diabetes. eHealthMe is studying from 56,160 Novolog users. Check the latest studies of Novolog.

On Jul, 20, 2026

77 people who take Exforge and Novolog together, and have interactions are studied.

What are the common drug interactions of Exforge and Novolog, by gender? *:

female:

Drug ineffective
Dyspnoea (difficult or laboured respiration)
Dyspnoea exertional (breathlessness or shortness of breath)
Glycosylated haemoglobin increased
Hypercoagulation (increased tendency for clotting of the blood)
Hypernatraemia (an abnormally high plasma concentration of sodium ions)
Hypervolaemia (abnormally increased volume of blood)
Influenza
Memory impairment
Muscle spasms (muscle contraction)

male:

Chronic kidney disease
Anaemia (lack of blood)
Transient ischaemic attack (a transient episode of neurologic dysfunction caused by ischemia (loss of blood flow))
Acne (skin problems that cause pimples)
Adrenal insufficiency (a condition in which the adrenal glands do not produce adequate amounts of steroids)
Arthritis (form of joint disorder that involves inflammation of one or more joints)
Blood glucose increased
Chest pain
Diabetic ketoacidosis (diabetic ketoacidosis (dka) is high concentrations of ketone bodies)
Diplopia (double vision)

What are the common drug interactions of Exforge and Novolog, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Chronic kidney disease
Drug ineffective
Urine ketone body present
Abdominal pain
Abscess (pus)
Agitation (state of anxiety or nervous excitement)
Alanine aminotransferase increased
Antinuclear antibody positive
Aspartate aminotransferase increased
Asthma

50-59:

Thrombophlebitis superficial (swelling (inflammation) of a superficial vein caused by a blood clot)
Abasia (inability to walk)
Alopecia (absence of hair from areas of the body)
Aphasia (damage to the parts of the brain that control language)
Asthenia (weakness)
Breast cancer in situ
Dyspnoea (difficult or laboured respiration)
Feeling hot
Flushing (the warm, red condition of human skin)
Metastases to liver (cancer spreads to liver)

60+:

Chronic kidney disease
Renal failure (kidney dysfunction)
Arthralgia (joint pain)
Back pain
Nephropathy (damage to or disease of a kidney)
Obesity (having too much body fat)
Pain in extremity
Urinary tract infection
Fatigue (feeling of tiredness)
Gait disturbance

What are the existing conditions these people have? *

High Blood Pressure: 28 people, 36.36%
High Blood Cholesterol: 22 people, 28.57%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 20 people, 25.97%
Pain: 19 people, 24.68%
Indigestion: 9 people, 11.69%
Stress And Anxiety: 9 people, 11.69%
Fluid Retention (an abnormal accumulation of fluid in the blood): 8 people, 10.39%
Asthma: 8 people, 10.39%
Type 2 Diabetes: 7 people, 9.09%
Depression: 5 people, 6.49%

* Approximation only. Some reports may have incomplete information.

Do you take Exforge and Novolog?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously